NCT02184533View on ClinicalTrials.gov

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate CancerMultiple MyelomaPlasmacytoma
Interventions
DRUG

sodium selenite

Given PO

RADIATION

radiation therapy

Undergo radiation therapy

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

OTHER

questionnaire administration

Ancillary studies

Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT02184533 - Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer | Biotech Hunter | Biotech Hunter